SARAH CLARK: Open Payments
NPI 1437932233 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 27 payments from 7 companies in 2025. Trend: 2023 $75 · 2024 $506 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 9 | $293 |
| E.R. Squibb & Sons, L.L.C. | 5 | $144 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Collegium Pharmaceutical, Inc. | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Corium, LLC | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: ARISTADA, COBENFY, LYBALVI, REXULTI, Jornay PM, CAPLYTA, Azstarys, Qelbree.
Industry payments across CO — which companies pay providers there.
